By Counterforce Health Team in Trikafta / Kaftrio (elexacaftor/tezacaftor/ivacaftor) —

Do You Qualify for Trikafta Coverage by Blue Cross Blue Shield in Virginia? Decision Tree & Next Steps

Quick Answer: Trikafta requires prior authorization from Blue Cross Blue Shield (BCBS) Virginia plans. You qualify if you have cystic fibrosis with at least one F508del mutation (or another responsive CFTR variant), are 2+ years old, and have proper genetic testing documentation. Submit via Availity's ICR tool or fax 844-512-7020. If denied, Virginia's external review process through the State Corporation Commission can overturn decisions within 45 days. Start by gathering your CFTR genotype report and CF diagnosis (ICD-10: E84.0-E84.9).

Table of Contents

  1. How to Use This Decision Tree
  2. Eligibility Triage: Do You Qualify?
  3. If "Likely Eligible": Document Checklist & Submission
  4. If "Possibly Eligible": Tests to Request
  5. If "Not Yet Eligible": Alternatives & Exception Requests
  6. If Denied: Virginia Appeals Path
  7. Coverage Requirements at a Glance
  8. Common Denial Reasons & Solutions
  9. Patient Assistance Programs
  10. FAQ

How to Use This Decision Tree

This guide helps Virginia residents determine if they qualify for Trikafta (elexacaftor/tezacaftor/ivacaftor) coverage through Blue Cross Blue Shield plans, including Anthem Blue Cross Blue Shield Virginia (HealthKeepers).

Start here: Answer the eligibility questions in section 2, then follow the path that matches your situation. Each section includes specific documents, submission methods, and timelines based on Virginia insurance regulations and BCBS policies.

Note: This applies to commercial BCBS plans in Virginia. Medicaid and Medicare Part D have different processes.

Eligibility Triage: Do You Qualify?

Primary Requirements Checklist

Check all that apply:

✓ Diagnosis confirmed? Cystic fibrosis diagnosis with ICD-10 codes E84.0-E84.9
✓ Age requirement? 2 years or older
✓ Genetic eligibility? At least one F508del mutation OR another CFTR mutation responsive to Trikafta
✓ Specialist involved? Pulmonologist or CF specialist prescription
✓ Insurance active? Current BCBS Virginia coverage

Severity & Prior Therapy Assessment

Additional factors BCBS may consider:

  • Baseline lung function (FEV1 measurements)
  • Exacerbation history in past 12 months
  • Prior CFTR modulator trials (Kalydeco, Orkambi, Symdeko) and outcomes
  • Sweat chloride test results
  • Growth parameters (BMI, height/weight percentiles for pediatric patients)

Results Interpretation

"Likely Eligible" → Continue to Section 3

  • All primary requirements met
  • Clear CF diagnosis with responsive genotype
  • Specialist support documented

"Possibly Eligible" → Continue to Section 4

  • Missing genetic testing or unclear genotype
  • CF diagnosis present but limited documentation
  • Age/severity questions

"Not Yet Eligible" → Continue to Section 5

  • Missing CF diagnosis
  • Non-responsive genotype
  • Age under 2 years

If "Likely Eligible": Document Checklist & Submission

Required Documentation

Medical Records:

  • CF diagnosis with ICD-10 code (E84.0-E84.9)
  • CFTR genotype report showing F508del or responsive mutation
  • Sweat chloride test results (≥60 mmol/L on two occasions)
  • Baseline pulmonary function tests (FEV1)
  • Growth/nutrition assessment

Clinical Notes:

  • Specialist consultation notes
  • Current symptoms and functional status
  • Prior therapy history and outcomes
  • Treatment goals and expected benefits

Insurance Information:

  • BCBS member ID and group number
  • Prior authorization form (if required by specific plan)

Submission Process

Primary Method: Availity Interactive Care Reviewer (ICR)

  1. Log into Availity provider portal
  2. Navigate to Prior Authorization tool
  3. Select "Pharmacy" for Trikafta requests
  4. Upload all supporting documents
  5. Submit electronically

Alternative Methods:

  • Pharmacy PA Fax: 844-512-7020
  • Medical Injectable Fax: 844-512-7022
  • Expedited Requests: 888-235-8390

Timeline Expectations

  • Standard Review: 5-15 business days
  • Expedited Review: 72 hours (if serious harm risk)
  • Auto-approval: Some cases via ICR system
Tip: Use NDC codes for Trikafta and reference FDA labeling in your submission to strengthen the medical necessity case.

If "Possibly Eligible": Tests to Request

Missing Genetic Testing

If genotype unknown or incomplete:

  1. Request comprehensive CFTR panel including:
    • F508del screening (most common)
    • Extended CFTR mutation analysis (271+ responsive variants)
    • Deletion/duplication analysis if needed
  2. Required testing standards:
    • FDA-cleared CFTR genetic test
    • Laboratory with CFTR2 database access
    • Results showing specific mutations, not just "positive/negative"

Documentation Gaps

Common missing elements:

  • Formal CF diagnosis from specialist
  • Sweat chloride confirmation testing
  • Baseline pulmonary function measurements
  • Prior therapy documentation with specific outcomes

Resubmission Timeline

  • Gather missing tests: 2-4 weeks typical
  • Schedule specialist visit: 1-3 weeks
  • Resubmit PA: Within 6 months of original request
Note: Genetic testing for CFTR mutations is covered by most BCBS plans when medically necessary for CF diagnosis or treatment decisions.

If "Not Yet Eligible": Alternatives & Exception Requests

Alternative Therapies by Genotype

If Trikafta not indicated:

  • Kalydeco (ivacaftor): G551D and other gating mutations
  • Orkambi (lumacaftor/ivacaftor): F508del homozygous, 2+ years
  • Symdeko (tezacaftor/ivacaftor): F508del with residual function mutations

Exception Request Strategy

For non-standard cases:

  1. Document why standard therapy insufficient
  2. Provide evidence of potential responsiveness
  3. Include specialist letter of medical necessity
  4. Reference published case studies or compassionate use data

Preparing for Future Eligibility

  • Monitor FDA label expansions
  • Maintain current CF specialist care
  • Document disease progression
  • Track new genotype research

If Denied: Virginia Appeals Path

Level 1: Internal Appeal (BCBS)

Timeline: Within 180 days of denial notice
Decision time: 30 days standard, 72 hours expedited
Required documents:

  • Original denial letter
  • Complete medical records
  • Physician letter of medical necessity
  • New supporting evidence

Submission methods:

  • Availity portal (preferred)
  • Member services phone line
  • Written appeal to address on denial notice

Level 2: External Review (Virginia SCC)

When to use: After BCBS final denial or 30+ days without response
Timeline: Within 120 days of final internal denial
Decision time: 45 days standard, 72 hours expedited

Required form: Form 216-A (External Review Request)

Submission options:

  • Email: [email protected]
  • Fax: (804) 371-9915
  • Mail: State Corporation Commission, Bureau of Insurance – External Review, P.O. Box 1157, Richmond, VA 23218
Virginia Advantage: The State Corporation Commission's external review process has helped many patients overturn wrongful denials. Independent medical reviewers evaluate cases based solely on medical evidence and FDA-approved indications.

Expedited Appeals

Available when delay could seriously jeopardize:

  • Life or health
  • Ability to regain maximum function
  • Treatment of cancer (special Virginia provision)

Timeline: 72 hours for medical necessity, 6 business days for experimental treatment denials

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization PA required before coverage BCBS formulary, provider portal Anthem VA PA Requirements
CF Diagnosis ICD-10: E84.0-E84.9 Medical records, specialist notes FDA Trikafta Label
Genetic Testing F508del+ or responsive mutation CFTR panel results CFTR2 Database
Age Limit 2+ years Birth certificate, medical records FDA Approved Indication
Specialist Rx Pulmonologist or CF center Prescription, consultation notes BCBS Medical Policy
Quantity Limits 28-day supply typical Pharmacy benefits Plan formulary

Common Denial Reasons & Solutions

Denial Reason How to Overturn Required Documents
"Missing genotype" Submit CFTR panel results FDA-cleared genetic test showing F508del or responsive mutation
"Not medically necessary" Provide specialist letter CF diagnosis, baseline labs, treatment goals, FDA indication
"Step therapy required" Document prior failures Medical records showing inadequate response to Kalydeco, Orkambi, or Symdeko
"Non-formulary" Request formulary exception Medical necessity letter, lack of alternatives documentation
"Quantity exceeded" Justify dosing Specialist prescription with rationale, FDA dosing guidelines
From our advocates: We've seen denials overturned when families provide comprehensive genetic testing results upfront, including both parents' carrier status when relevant. This demonstrates thoroughness and can prevent delays in the review process.

Patient Assistance Programs

Vertex GPS Co-pay Assistance Program

For commercially insured patients (including BCBS):

  • Reduces copays up to $20,000 annually
  • May reduce costs to $0 for eligible patients
  • Automatic reenrollment if therapy continues

Enrollment:

  1. Doctor completes enrollment form
  2. Fax to 1-888-952-5933
  3. Patient speaks with case manager
  4. Online enrollment at vertexgpsportal.com

Contact: 1-877-752-5933 (press 2), Mon-Fri 8:30am-7pm ET

Free Medication Program

Journavx+you Patient Assistance Program:

  • For uninsured or unable to afford Trikafta
  • Provides free medication to eligible patients
  • Contact Vertex for application details

Virginia-Specific Resources

  • Virginia Health Care Foundation (vhcf.org) for supplemental CF support
  • Cystic Fibrosis Foundation Compass program for navigation assistance

FAQ

How long does BCBS prior authorization take in Virginia?
Standard PA decisions take 5-15 business days. Expedited requests (when delay risks serious harm) must be decided within 72 hours. Use Availity's ICR tool for fastest processing.

What if Trikafta is non-formulary on my BCBS plan?
Request a formulary exception by submitting medical necessity documentation showing no adequate alternatives exist. Include specialist letter explaining why Trikafta is specifically needed for your genotype.

Can I request an expedited appeal in Virginia?
Yes, if waiting for standard review could seriously jeopardize your health. Virginia allows expedited external review within 72 hours for medical necessity denials, and even allows expedited review for cancer treatments without exhausting internal appeals.

Does step therapy apply if I've tried other CFTR modulators outside Virginia?
Yes, document all prior therapies regardless of where they were tried. Include medical records showing inadequate response, intolerance, or contraindications to other CFTR modulators like Kalydeco or Orkambi.

What genetic testing do I need for Trikafta coverage?
You need FDA-cleared CFTR genetic testing showing at least one F508del mutation or another responsive CFTR variant. Simple carrier screening isn't sufficient—you need comprehensive mutation analysis if genotype is unknown.

How much does Trikafta cost without insurance?
The annual list price is approximately $370,000. Most patients with commercial insurance qualify for Vertex's copay assistance program, which can reduce out-of-pocket costs significantly.

Sources & Further Reading

About Counterforce Health: Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals by creating evidence-backed, targeted rebuttals. Our platform ingests denial letters, plan policies, and clinical notes to draft point-by-point appeals aligned with payer requirements, pulling the right medical evidence and meeting all procedural deadlines.

When navigating complex prior authorization requirements like those for Trikafta, having the right documentation and appeal strategy can make the difference between approval and denial. Counterforce Health's automated system ensures nothing falls through the cracks, from genetic testing requirements to Virginia-specific appeal timelines.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual circumstances and specific plan terms. Always consult with your healthcare provider and insurance plan directly for coverage determinations. For questions about Virginia insurance regulations, contact the State Corporation Commission Bureau of Insurance at 1-877-310-6560.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.